Jayvadan Vaishnav

Employment

• Parul University Assistant Professor
  2023 - Present
• Maharaja Sayajirao University of Baroda SRF (Senior Research Fellow)
  2020 - 2020
• The Maharaja Sayajirao University of Baroda Faculty of Science Ph.D. Scholar
  2019 - 2023
• The Maharaja Sayajirao University of Baroda Faculty of Science JRF (Junior Research Fellow)
  2018 - 2020

Education

• Maharaja Sayajirao University of Baroda Ph.D.
  2019 - 2024
• The Maharaja Sayajirao University of Baroda Faculty of Science M.Sc
  2016 - 2018
• C U Shah Science College B.Sc
  2013 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Nardilysin: classical functions and new horizons in autoimmunity
  Frontiers in Immunology 2026 DOI: 10.3389/fimmu.2026.1858534
  +Save
• HIGH-THROUGHPUT SEQUENCING-BASED IDENTIFICATION AND FUNCTIONAL ANNOTATION OF GENETIC VARIANTS ASSOCIATED WITH PHENOTYPIC TRAITS
  Genetics and Molecular Research 2026 DOI: 10.4238/j1kdgp28
  +Save
• Unveiling the multifaceted potential of 2D SbTeI: electronic, optical, and thermodynamic properties for advanced optoelectronics
  European Physical Journal B 2026 DOI: 10.1140/epjb/s10051-026-01188-1
  +Save
• Enhancing Wildlife Conservation through Sensor and Deep Learning Integration for Accurate Animal Behavior Tracking
  Journal of Wireless Mobile Networks Ubiquitous Computing and Dependable Applications 2025 DOI: 10.58346/JOWUA.2025.I3.015
  +Save
• Regulatory T Cells and Autoimmune Diseases
  Regulatory T Cells and Autoimmune Diseases 2024 DOI: 10.1016/b978-0-443-13947-5.00037-3
  +Save
• Role of regulatory T cells in pathogenesis and therapeutics of alopecia areata
  Regulatory T Cells and Autoimmune Diseases 2024 DOI: 10.1016/B978-0-443-13947-5.00037-3
  +Save
• V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases
  Immunobiology 2022 DOI: 10.1016/j.imbio.2022.152274
  +Save
• Altered Levels of Negative Costimulatory Molecule V-Set Domain-Containing T-Cell Activation Inhibitor-1 (VTCN1) and Metalloprotease Nardilysin (NRD1) are Associated with Generalized Active Vitiligo
  Immunological Investigations 2022 DOI: 10.1080/08820139.2022.2097091
  +Save
• Current paradigms of pathogenesis and challenges in vitiligo translational research
  Translational Autoimmunity Challenges for Autoimmune Diseases Volume 5 2022 DOI: 10.1016/B978-0-323-85389-7.00005-3
  +Save
• Elevated X-Box Binding Protein1 Splicing and Interleukin-17A Expression Are Associated With Active Generalized Vitiligo in Gujarat Population
  Frontiers in Immunology 2022 DOI: 10.3389/fimmu.2021.801724
  +Save